Nianwu Wang
Overview
Explore the profile of Nianwu Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang S, Liu Y, Wang C, Xiang W, Wang N, Peng L, et al.
Orthop Surg
. 2023 Aug;
15(11):2749-2765.
PMID: 37620876
Osteoarthritis (OA) causes disability and significant economic and social burden. Cartilage injury is one of the main pathological features of OA, and is often manifested by excessive chondrocyte death, inflammatory...
2.
Mao W, Yu Q, Wang K, Ma Q, Zheng Y, Zhang G, et al.
Front Oncol
. 2022 Oct;
12:1032295.
PMID: 36267960
[This corrects the article DOI: 10.3389/fonc.2022.791332.].
3.
Li Y, Wang N, Hasan M, Pang H
Mol Pharm
. 2022 Sep;
19(11):4123-4134.
PMID: 36070496
Liposomes have been widely used as a drug delivery vector. One way to further improve its therapeutic efficacy is to increase the cell entry efficiency. Covalent conjugation with cell-penetrating peptides...
4.
Mao W, Yu Q, Wang K, Ma Q, Zheng Y, Zhang G, et al.
Front Oncol
. 2022 Jul;
12:791332.
PMID: 35903698
N6-methyladenosine (m6A) is the most abundant internal modification on eukaryotic mRNAs. There is increasing evidence that m6A plays a key role in tumor progression, so it is important to analyze...
5.
Wang N, Wang W, Mao W, Kuerbantayi N, Jia N, Chen Y, et al.
Biomed Res Int
. 2021 Jan;
2021:6905985.
PMID: 33506032
Background: The majority of lung cancers are adenocarcinomas, with the proportion being 40%. The patients are mostly diagnosed in the middle and late stages with metastasis and easy recurrence, which...